Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide-Reference-Cited by-同舟云学术

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide

Published:2018-01 Issue:1 Volume:24 Page:119-126
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Raiola Anna Maria,Risitano Antonio,Sacchi Nicoletta,Giannoni Livia,Signori Alessio,Aquino Sara,Bregante Stefania,Di Grazia Carmen,Dominietto Alida,Geroldi Simona,Ghiso Anna,Gualandi Francesca,Lamparelli Teresa,Tedone Elisabetta,Van Lint Maria Teresa,Varaldo Riccardo,Ibatici Adalberto,Marani Carlo,Marotta Serena,Guolo Fabio,Avenoso Daniele,Garbarino Lucia,Pane Fabrizio,Bacigalupo Andrea,Angelucci Emanuele^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors;Anasetti;Transfus Sci,1994

2. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma;Anasetti;Hum Immunol,1990

3. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood,2007

4. Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donors;Ciurea;Biol Blood Marrow Transplant,2011

5. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome;Flomenberg;Blood,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA structure and function in hematopoietic-cell transplantation;Best Practice & Research Clinical Haematology;2024-09

2. Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation;Frontiers in Immunology;2024-08-19

3. Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience;Annals of Hematology;2024-06-15

4. Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations;American Journal of Hematology;2024-03-28

5. HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.;Mediterranean Journal of Hematology and Infectious Diseases;2024-01-01